Oncogenic transformation of human cells: Shortcomings of rodent model systems

Trends in Molecular Medicine

Volumn 10, Issue 11, 2004, Pages 542-548

  Akagi, Tsuyoshi ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; CELL IMMORTALIZATION; CELL LINE; CELL STRAIN; CELL STRUCTURE; CELL TRANSFORMATION; CYTOLOGY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FIBROBLAST; HUMAN; IN VIVO STUDY; MOLECULAR BIOLOGY; MUTAGENESIS; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; RODENT; SENESCENCE; SIGNAL TRANSDUCTION;

ANIMALS; CELL AGING; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MITOGENS; MODELS, ANIMAL; ONCOGENE PROTEINS; RODENTIA; SIGNAL TRANSDUCTION; TELOMERE;

ANIMALIA; RODENTIA;

EID: 7244226366     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.09.001     Document Type: Review

References (68)

1. J.A. DiPaolo Relative difficulties in transforming human and animal cells in vitro J. Natl. Cancer Inst. 70 1983 3 8
2. T. Kuroki, and N.H. Huh Why are human cells resistant to malignant cell transformation in vitro? Jpn. J. Cancer Res. 84 1993 1091 1100
3. H.E. Ruley Transforming collaborations between ras and nuclear oncogenes Cancer Cells 2 1990 258 268
4. W.C. Hahn, and R.A. Weinberg Modelling the molecular circuitry of cancer Nat. Rev. Cancer 2 2002 331 341
5. A. Rangarajan, and R.A. Weinberg Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice Nat. Rev. Cancer 3 2003 952 959
6. H.E. Ruley Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture Nature 304 1983 602 606
7. C.J. Sherr, and R.A. DePinho Cellular senescence: mitotic clock or culture shock? Cell 102 2000 407 410
8. N.F. Mathon, and A.C. Lloyd Cell senescence and cancer Nat. Rev. Cancer 1 2001 203 213
9. W.E. Wright, and J.W. Shay Historical claims and current interpretations of replicative aging Nat. Biotechnol. 20 2002 682 688
10. F. Ishikawa Cellular senescence, an unpopular yet trustworthy tumor suppressor mechanism Cancer Sci. 94 2003 944 947
11. K.R. Prowse, and C.W. Greider Developmental and tissue-specific regulation of mouse telomerase and telomere length Proc. Natl. Acad. Sci. U. S. A. 92 1995 4818 4822
12. S. Parrinello Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts Nat. Cell Biol. 5 2003 741 747
13. N.F. Mathon Lack of replicative senescence in normal rodent glia Science 291 2001 872 875
14. D.G. Tang Lack of replicative senescence in cultured rat oligodendrocyte precursor cells Science 291 2001 868 871
15. R.D. Ramirez Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions Genes Dev. 15 2001 398 403
16. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells Nature 396 1998 84 88
17. A.G. Bodnar Extension of life-span by introduction of telomerase into normal human cells Science 279 1998 349 352
18. INK4a Cell 88 1997 593 602
19. C.P. Morales Absence of cancer-associated changes in human fibroblasts immortalized with telomerase Nat. Genet. 21 1999 115 118
20. W.C. Hahn Enumeration of the simian virus 40 early region elements necessary for human cell transformation Mol. Cell. Biol. 22 2002 2111 2123
21. Cip1/Waf1 functions permits Ras-induced anchorage-independent growth in telomerase-immortalized human fibroblasts Mol. Cell. Biol. 23 2003 2859 2870
22. P.M. Voorhoeve, and R. Agami The tumor-suppressive functions of the human INK4A locus Cancer Cell 4 2003 311 319
23. W.C. Hahn Creation of human tumour cells with defined genetic elements Nature 400 1999 464 468
24. W. Chen Identification of specific PP2A complexes involved in human cell transformation Cancer Cell 5 2004 127 136
25. B. Elenbaas Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells Genes Dev. 15 2001 50 65
26. J.N. Rich A genetically tractable model of human glioma formation Cancer Res. 61 2001 3556 3560
27. A.S. Lundberg Immortalization and transformation of primary human airway epithelial cells by gene transfer Oncogene 21 2002 4577 4586
28. J. Liu A genetically defined model for human ovarian cancer Cancer Res. 64 2004 1655 1663
29. W.C. Hahn, and R.A. Weinberg Rules for making human tumor cells N. Engl. J. Med. 347 2002 1593 1603
30. S. Brookes INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence EMBO J. 21 2002 2936 2945
31. INK4a confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts Mol. Cell. Biol. 22 2002 8135 8143
32. INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes Cancer Cell 4 2003 301 310
33. Y.R. Seger Transformation of normal human cells in the absence of telomerase activation Cancer Cell 2 2002 401 413
34. M. Lazarov CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis Nat. Med. 8 2002 1105 1114
35. M. Dajee NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia Nature 421 2003 639 643
36. Q. Deng High-intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts J Biol Chem 279 2003 1050 1059
37. T. Akagi Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation Proc. Natl. Acad. Sci. U. S. A. 100 2003 13567 13572
38. D. Michalovitz Activated Ha-ras can cooperate with defective simian virus 40 in the transformation of nonestablished rat embryo fibroblasts J. Virol. 61 1987 2648 2654
39. E. Sahai Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility EMBO J. 20 2001 755 766
40. G. Pawlak, and D.M. Helfman Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts Mol. Biol. Cell 13 2002 336 347
41. J. Zuber A genome-wide survey of RAS transformation targets Nat. Genet. 24 2000 144 152
42. R. Treisman Regulation of transcription by MAP kinase cascades Curr. Opin. Cell Biol. 8 1996 205 215
43. B. Wasylyk Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway Trends Biochem. Sci. 23 1998 213 216
44. C.A. Hazzalin, and L.C. Mahadevan MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3 2002 30 40
45. R. Eferl, and E.F. Wagner AP-1: a double-edged sword in tumorigenesis Nat. Rev. Cancer 3 2003 859 868
46. C. Wasylyk Reversion of Ras transformed cells by Ets transdominant mutants Oncogene 9 1994 3665 3673
47. R. Johnson Cellular transformation and malignancy induced by ras require c-jun Mol. Cell. Biol. 16 1996 4504 4511
48. F. Mechta Transformation by ras modifies AP1 composition and activity Oncogene 14 1997 837 847
49. L. Casalino Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization Mol. Cell. Biol. 23 2003 4401 4415
50. N.M. Hamad Distinct requirements for Ras oncogenesis in human versus mouse cells Genes Dev. 16 2002 2045 2057
51. S.L. Campbell Increasing complexity of Ras signaling Oncogene 17 1998 1395 1413
52. H. Fukazawa, and Y. Uehara U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways Cancer Res. 60 2000 2104 2107
53. H. Reuveni Reversal of the Ras-induced transformed phenotype by HR12, a novel ras farnesylation inhibitor, is mediated by the Mek/Erk pathway J. Cell Biol. 151 2000 1179 1192
54. A.H. Lund Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice Nat. Genet. 32 2002 160 165
55. K. Itahana Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1 Mol. Cell. Biol. 23 2003 389 401
56. C.M. Beausejour Reversal of human cellular senescence: roles of the p53 and p16 pathways EMBO J. 22 2003 4212 4222
57. A. Balmain, and H. Nagase Cancer resistance genes in mice: models for the study of tumour modifiers Trends Genet. 14 1998 139 144
58. P. Demant Cancer susceptibility in the mouse: genetics, biology and implications for human cancer Nat. Rev. Genet. 4 2003 721 734
59. ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1 Proc. Natl. Acad. Sci. U. S. A. 95 1998 2429 2434
60. INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB Oncogene 22 2003 2285 2295
61. D. Cozma A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers Genome Res. 12 2002 969 975
62. C.A. Ruivenkamp Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers Nat. Genet. 31 2002 295 300
63. A. Ewart-Toland Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human Nat. Genet. 34 2003 403 412
64. P. Dumont The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat. Genet. 33 2003 357 365
65. S. Kong Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer Cancer Res. 60 2000 249 252
66. A.F. Chambers, and A.B. Tuck Ras-responsive genes and tumor metastasis Crit. Rev. Oncog. 4 1993 95 114
67. T. Van Dyke, and T. Jacks Cancer modeling in the modern era: progress and challenges Cell 108 2002 135 144
68. J. Jonkers, and A. Berns Conditional mouse models of sporadic cancer Nat. Rev. Cancer 2 2002 251 265